Provider

Elena Viboch, partner at General Catalyst, discusses her predictions for biotech and health tech investing and how startups can grow in a more constrained economic environment.

Ian Shakil, founder, director and chief strategy officer at Augmedix, discusses the company's role in the evolution of medical documentation.

Although investment slowed for startups, leaders noted several big deals in digital health, particularly among retail players.

Execs said investors will focus on companies with evidence of market fit, established business models and those achieving measurable health outcomes.   

The year was plagued by layoffs, slowing investments and an increased need for companies to prove their market value.

Also, Lunit signed multiple contracts this week to deliver its AI imaging software in Hong Kong, Mongolia, and Brazil.

DailyEndorphin's corporate team challenges will be added to Wellable's Wellness Platform.

Nomi Health appointed its first chief product officer, and Hims & Hers announced that its first chief medical officer has returned to the role.

Aegis Ventures' John Beadle discusses partnerships between venture capital firms and health systems, the move from direct-to-consumer to business-to-business models and what digital health investment could look like next year.

The company seeks to meet the rising demand for specialised care across Southeast Asia.